Cellorgane® Multi-Complex 3G Formula 6 Lungs

Respiratory System

Problem

With age, organ function progressively decreases due to cell deterioration, caused mainly by oxidative stress; this generates vitality and quality of life losses. This organic sub function predisposes to chronic degenerative diseases. Damage by oxidative stress, chronic respiratory disease.

Uses

Chronic Obstructive Pulmonary Disease (COPD), asthma, bronchiectasis, Cystic Fibrosis. As a preventive in smokers, seasonal infectious diseases and aging.

Solution

The contribution of cellular cytokines and growth factors in embryonic extracts has a refreshing and revitalizing effect at the cellular level, which increases the specific functionality of the organ to be treated.
Antioxidant enzymes neutralize free radicals, thereby reducing damage from oxidative stress.

Composition

Oral CELLORGANE 6 Each 500-mg enteric coated tablet contains: Opotherapic cell extracts: Lung 50%, embryonic endoderm 10%, Thymus 10%, Placenta 10%; Antioxidant enzyme complex: Superoxide dismutase, glutathione peroxidase, Glutathione reductase, glutathione transferase; Maltodextrin 20% and stabilizers.

Action Mechanisms

Formula components reach the cells directly or indirectly, in the case of oral products, by bloodstream, and are selectively incorporated into the cells through various means of cellular transport. It acts revitalizing the respiratory system at the cellular level, improving its functionality and reducing the risk of degenerative diseases.

Contraindications

  • Allergies to animal proteins.
  • Allergy to any of its components.
  • Pregnancy and lactation.

Posology

Chronic Obstructive Pulmonary Disease (COPD), Asthma, Bronchiectasis, Cystic Fibrosis
Orally: Two tablets in the morning and 2 at night, for at least six months.
Smoking and seasonal infectious processes
Orally: Two tablets in the morning and 2 at night, for at least three months.
The tablets are taken in the morning on an empty stomach and at night before dinner (30 minutes before meals).

Note:
The dose may be increased according to the clinical picture of the patient and the physician's discretion; the results depend on the completion of treatment.

Adjuvant treatment with:

Bronchodilators

Aminophylline, Theophylline, Tiotropium, albuterol, levalbuterol
Antihistamines Loratadine, Desloratadine, cetirizine, levocetirizine
Antihypertensive and heart failure
  • Calcium antagonists: Nifedipine
  • ACE inhibitors: Enalapril, Captopril
  • ARB-II: losartan, candesartan
  • Beta-blockers: Atenolol, Metoprolol, Carvedilol, Bisoprolol
  • Thiazide diuretics: Hydrochlorothiazide, chlorthalidone, indapamide, xipamide, Ameride (thiazide & K+ saver)
Diuretics
  • Loop diuretics: Furosemide, Amiloride
  • Thiazide and analogues: IDEM (above)
  • K + Savers: Spironolactone
  • Osmotic: Mannitol
Statins

Selective, competitive inhibitors of HMG-CoA reductase: atorvastatin, simvastatin, pravastatin

Coronary vasodilators
  • Antianginal: Calcium antagonists - Nifedipine
  • Competitive antagonist of beta 1 and beta 2 adrenergic receptors: Propranolol
Heart failure Digitalis: Digoxin
Venous insufficiency
  • Venotonic and vasculoprotective drugs: Diosmin, Hidrosmin, Horse Chestnut Seed
Alzheimer
  • Reversible inhibitor of the enzyme acetylcholinesterase: Donepezil, Galantamine
  • NMDA receptor antagonist: Memantine
  • Neurometabolic stimulator: Piracetam
  • Porcine-brain derived peptide preparation: Cerebrolysin
  • Cholinesterase inhibitors: Rivastigmine
Chemotherapy
  • Methotrexate, actinomycin D, vincristine, ifosfamide, Raltitrexed, Bevacizumab, Irinotecan, oxaliplatin, cetuximab, capecitabine, carboplatin, tamoxifen, cisplatin, Megestrol
  • Gestonorone, Anastrozole, Paclitaxel, Vinorelbine, Trastuzumab, leuprorelin, Diethylstilbestrol, Nilutamide, epirubicin, among others
Anti-anemic Iron
Erectile dysfunction (ED) cyclic GMP-specific phosphodiesterase type 5 (PDE5): Sildenafil
© 2017 Biocell Ultravital. Privacy
Like Us on Facebook Follow Us on Twitter